CryoTherapeutics secures €10M in a Series B extension round led by Noshaq and existing investors to develop a next-gen catheter system to treat inflamed atherosclerotic plaque.

CryoTherapeutics has raised €10 million in a Series B extension round with equity and non-dilutive funding. The investment will support additional clinical evaluation of its novel technology based on innovative cryotherapy to treat inflamed atherosclerotic plaque, as well as the development of its next-generation catheter system for advanced clinical studies and early commercialisation, and the expansion of its team in Liège.